Hexarelin Acetate: The "Cardiac-Protective" Secretagogue

Disclaimer: Hexarelin is a synthetic growth hormone secretagogue (GHRP). While extensively researched for its potent GH-releasing and cardioprotective properties, it is not FDA-approved for human use and is strictly prohibited by WADA. This information reflects 2025/2026 research into pituitary and cardiac health.

What is Hexarelin?

Hexarelin is a synthetic six-amino-acid peptide (hexapeptide) and one of the most potent members of the Growth Hormone Releasing Peptide (GHRP) family. It shares structural similarities with GHRP-6 but is chemically more stable and functionally more powerful.

Unlike "softer" secretagogues like Ipamorelin, Hexarelin is known for its high-intensity pulses and its unique ability to interact with the CD36 receptor, which is primarily located in the heart and blood vessels.

• Mechanism: Ghrelin Receptor Agonist + CD36 Receptor Ligand.
• Primary Target: Pituitary gland (GH release) and Myocardium (Cardioprotection).
• Key Feature: Does not significantly increase appetite (unlike GHRP-6).

Mechanism of Action: The Dual-Pathway Edge

Hexarelin is unique because it works through two distinct physiological pathways:

1. The Pituitary Pathway: It mimics ghrelin to trigger a massive, immediate release of Growth Hormone (GH). This leads to increased IGF-1 production, aiding in muscle repair and fat metabolism.
2. The Cardiac Pathway (CD36): This is the "Hexarelin Signature." It binds to CD36 receptors in the heart, where it is researched for its ability to increase Left Ventricular Ejection Fraction (LVEF), protect against ischemia-reperfusion injury, and reduce cardiomyocyte apoptosis (cell death).

2026 Research Note: New studies suggest Hexarelin's cardioprotective effects are independent of its GH-releasing activity, making it a "stand-alone" candidate for research into heart failure and vascular recovery.

Research Protocols (5mg Vial)

Hexarelin is famous for rapid desensitization. If used too frequently at high doses, the pituitary receptors "downregulate," and the GH-releasing effect diminishes.

Reconstitution (2.5 mL BAC Water)

For a 5 mg vial, adding 2.5 mL of Bacteriostatic Water (BAC) is the standard for scannable dosing.

Total Vial: 5,000 mcg (5 mg)

Concentration: 2,000 mcg per 1 mL (20 mcg per unit)

Research Dosing Roadmap (Subcutaneous)

Cycle Strategy: Due to the desensitization factor, a common 2026 protocol is the "4-Week Burst": 4 weeks of daily use followed by a 4-week break to reset pituitary sensitivity.

Frequently Asked Questions

Does it raise Cortisol and Prolactin?

Yes. Unlike Ipamorelin, Hexarelin can cause mild, transient elevations in Cortisol and Prolactin. At standard research doses (100–200 mcg), these increases are generally within the physiological range, but they are a factor in why many researchers choose shorter cycles.

Why is it called "Cardioprotective"?

In clinical models, Hexarelin has been shown to improve cardiac output and protect heart tissue during stress. Researchers often look at it as a "recovery" peptide for subjects with high cardiovascular strain.

When is the best time for administration?

Pre-workout (for the acute GH spike and cardiac benefit) or Before Bed (to align with the body's natural nocturnal GH pulse). It is generally advised to administer on an empty stomach (2 hours post-meal) for maximum GH response.

Is it stable?

Hexarelin is more stable than GHRP-6 but still requires a cold chain. Once reconstituted, it must be refrigerated (2-8°C). Researchers recommend using the vial within 14–21 days to ensure the peptide hasn't degraded.

Summary Checklist

• [ ] 1 Vial Hexarelin Acetate (5 mg).
• [ ] 2.5 mL Bacteriostatic Water.
• [ ] Subcutaneous injection (Stomach or Thigh).
• [ ] Strategy: 4 weeks on / 4 weeks off.

About PeptideDosing.co: We synthesize current research literature on peptide compounds for educational purposes. We do not sell peptides. Always consult qualified researchers and comply with local regulations.